BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 231443)

  • 1. Synergistic effect of 5'-amino-5'-deoxythymidine and 5-iodo-2'-deoxyuridine against Herpes Simplex virus infections in vitro.
    Fischer PH; Lee JJ; Chen MS; Lin TS; Prusoff WH
    Biochem Pharmacol; 1979 Dec; 28(23):3483-6. PubMed ID: 231443
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
    Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
    Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs.
    Katz E; Rosenblat O; Pisanty S
    Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):296-9. PubMed ID: 1656355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal inhibitary effect of 5-iodo-2'-deoxyuridine and thymidine into the cells infected with herpes simplex virus.
    Go T
    Nippon Ganka Gakkai Zasshi; 1972 Dec; 76(12):1567-85. PubMed ID: 4347378
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral activity of 5-iodo-2'-deoxyuridine and related drugs in human keratinocytes infected in vitro with herpes simplex virus type 1.
    Reuveni H; Bull CO; Landry ML; Milstone LM; Schwartz PM
    Skin Pharmacol; 1991; 4(4):291-7. PubMed ID: 1665069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of 5-iodo-5'-amino-2',5',dideoxyuridine by herpes simplex virus type 1 encoded thymidine kinase.
    Chen MS; Prusoff WH
    J Biol Chem; 1979 Oct; 254(20):10449-52. PubMed ID: 226542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU].
    Oshima K
    Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of herpes simplex virus type 1 thymidine kinase in the presence of thymidine analogues.
    Zucker ML; Mancini WR; Otto MJ; Lee JJ; Prusoff WH
    Antiviral Res; 1986 Mar; 6(2):69-81. PubMed ID: 3010857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incorporation of 5-iodo-5'-amino-2',5-dideoxyuridine and 5-iodo-2'-deoxyuridine into herpes simplex virus DNA. Relationship between antiviral activity and effects on DNA structure.
    Fischer PH; Chen MS; Prusoff WH
    Biochim Biophys Acta; 1980 Feb; 606(2):236-45. PubMed ID: 6243982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
    Cheng YC; Dutschman G; De Clercq E; Jones AS; Rahim SG; Verhelst G; Walker RT
    Mol Pharmacol; 1981 Jul; 20(1):230-3. PubMed ID: 6270535
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
    Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
    Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiviral activity of 5- and 5'-substituted thymidine analogs.
    Lin TS; Neenan JP; Cheng YC; Prusoff WH
    J Med Chem; 1976 Apr; 19(4):495-8. PubMed ID: 177781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.
    Nutter LM; Grill SP; Dutschman GE; Sharma RA; Bobek M; Cheng YC
    Antimicrob Agents Chemother; 1987 Mar; 31(3):368-74. PubMed ID: 3034143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical classification of herpes simplex virus types 1 and 2, and of intermediate strains on the basis of different susceptibilities of thymidine kinase to thymidine analogues.
    Just I; Dundaroff S; Falke D
    Acta Virol; 1976 Feb; 20(1):31-9. PubMed ID: 7938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses.
    Renis HE
    Antimicrob Agents Chemother; 1978 Apr; 13(4):613-7. PubMed ID: 208459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of herpes simplex virus to 5-iodo-2'-deoxyuridine].
    Cocchi P
    G Mal Infett Parassit; 1965 Dec; 17(12):874-6. PubMed ID: 4286637
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific herpes simplex virus-induced incorporation of 5-iodo-5'-amino-2',5'-dideoxyuridine into deoxyribonucleic acid.
    Chen MS; Ward DC; Prusoff WH
    J Biol Chem; 1976 Aug; 251(16):4833-8. PubMed ID: 182681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-herpes activity of deoxythymidine analogues: specific dependence on virus-induced deoxythymidine kinase.
    De Clercq E; Krajewska E; Descamps J; Torrence PF
    Mol Pharmacol; 1977 Sep; 13(5):980-4. PubMed ID: 197397
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the development of resistant strains of Type 1 herpes simplex virus to in vitro antiviral activity of 5-iodo-2'-deoxyuridine or ribavirin.
    Huffman JH; Allen LB; Sidwell RW
    Ann N Y Acad Sci; 1977 Mar; 284(1):233-8. PubMed ID: 212974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.